- Home
- FRPT vs CORT Comparison
FRPT vs CORT Comparison
Compare FRPT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPT
- CORT
- Stock Information
- Founded
- FRPT 2004
- CORT 1998
- Country
- FRPT United States
- CORT United States
- Employees
- FRPT N/A
- CORT N/A
- Industry
- FRPT Packaged Foods
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- FRPT Consumer Staples
- CORT Health Care
- Exchange
- FRPT Nasdaq
- CORT Nasdaq
- Market Cap
- FRPT 3.5B
- CORT 7.5B
- IPO Year
- FRPT 2014
- CORT N/A
- Fundamental
- Price
- FRPT $68.67
- CORT $71.72
- Analyst Decision
- FRPT Buy
- CORT Strong Buy
- Analyst Count
- FRPT 17
- CORT 4
- Target Price
- FRPT $128.50
- CORT $142.00
- AVG Volume (30 Days)
- FRPT 1.3M
- CORT 1.6M
- Earning Date
- FRPT 08-04-2025
- CORT 07-28-2025
- Dividend Yield
- FRPT N/A
- CORT N/A
- EPS Growth
- FRPT 54.83
- CORT 8.36
- EPS
- FRPT 0.31
- CORT 1.14
- Revenue
- FRPT $1,014,577,000.00
- CORT $685,446,000.00
- Revenue This Year
- FRPT $18.13
- CORT $35.83
- Revenue Next Year
- FRPT $18.40
- CORT $35.24
- P/E Ratio
- FRPT $220.76
- CORT $62.92
- Revenue Growth
- FRPT 23.25
- CORT 30.93
- 52 Week Low
- FRPT $66.75
- CORT $30.77
- 52 Week High
- FRPT $164.07
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- FRPT 39.80
- CORT 50.50
- Support Level
- FRPT $66.75
- CORT $66.49
- Resistance Level
- FRPT $72.37
- CORT $72.49
- Average True Range (ATR)
- FRPT 3.10
- CORT 2.85
- MACD
- FRPT 0.24
- CORT -0.09
- Stochastic Oscillator
- FRPT 27.90
- CORT 49.95
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.